TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
VYGR

Voyager Therapeutics Inc

Healthcare · Biotechnology

3.00$ -0.3% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Voyager Therapeutics Inc (VYGR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 72.2% of the shares are freely tradable; institutional investors hold 56.4%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 56.4%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 15.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 72.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 7.2%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 62Mio.

Largest Shareholders

Institutions

Institutions VYGR
Name Stake (%) Shares Change (%) Date
BlackRock Inc 9.04 5,568,381 -0.9 03/31/2026
Millennium Management LLC 7.21 4,442,951 +29.6 06/30/2026
Armistice Capital, LLC 5.68 3,500,000 -12.5 03/31/2026
Vestal Point Capital LP 4.87 3,002,936 +103.6 03/31/2026
Vanguard Capital Management, LLC 3.71 2,283,253 +0.0 03/31/2026
Opaleye Management Inc 1.92 1,185,000 +3.0 06/30/2026
Erste Asset Management GmbH 1.78 1,095,141 -8.4 03/31/2026
Geode Capital Management, LLC 1.70 1,049,978 -7.5 03/31/2026

Funds

Funds VYGR
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.71 1,671,885 +0.0 07/31/2026
iShares Russell 2000 ETF 2.20 1,355,369 -0.6 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?